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A novel approach to differentiate 
rat embryonic stem cells in vitro  
reveals a role for RNF12 in 
activation of X chromosome 
inactivation
Aristea Magaraki1, Agnese Loda1,2, Cristina Gontan1, sarra Merzouk1, esther sleddens-
Linkels1, stephen Meek3, Willy M. Baarends1, tom Burdon3 & Joost Gribnau1
X chromosome inactivation (XCI) is a mammalian specific, developmentally regulated process relying 
on several mechanisms including antisense transcription, non-coding RNA-mediated silencing, and 
recruitment of chromatin remodeling complexes. In vitro modeling of XCI, through differentiation 
of embryonic stem cells (esCs), provides a powerful tool to study the dynamics of XCI, overcoming 
the need for embryos, and facilitating genetic modification of key regulatory players. However, to 
date, robust initiation of XCI in vitro has been mostly limited to mouse pluripotent stem cells. Here, 
we adapted existing protocols to establish a novel monolayer differentiation protocol for rat ESCs to 
study XCI. We show that differentiating rat ESCs properly downregulate pluripotency factor genes, and 
present female specific Xist RNA accumulation and silencing of X-linked genes. We also demonstrate 
that RNF12 seems to be an important player in regulation of initiation of XCI in rat, acting as an Xist 
activator. our work provides the basis to investigate the mechanisms directing the XCI process in a 
model organism different from the mouse.
In mammals, X chromosome inactivation (XCI) ensures dosage compensation of sex chromosomal genes 
between females (XX) and males (XY)1,2. The process of XCI occurs early during female embryonic development 
and is mediated by a multitude of epigenetic mechanisms that result in the complete transcriptional inactivation 
of one entire X chromosome within the nucleus of every female somatic cell. In eutherians, initiation of XCI is 
mediated by the long non-coding RNA Xist3–6. During XCI, Xist RNA spreads in cis along the entire length of the 
X chromosome and triggers chromosome-wide silencing of X-linked genes by recruitment of a plethora of chro-
matin remodelers7–10. The study of XCI relies both on in vivo and in vitro models that allow genetic manipulation 
of the factors involved, and the vast majority of our current knowledge has been achieved by using the mouse as a 
model organism. In vivo studies have shown that XCI starts around the 4–8 cell stage of female mouse embryonic 
development and is initially imprinted (iXCI), resulting in exclusive inactivation of the paternal X chromosome 
(Xp)11–14. Later in development, at the blastocyst stage (~E4.5), the Xp becomes reactivated in the inner cell mass 
(ICM) of the embryo, whereas iXCI persists in the extra-embryonic lineages12,13. Reactivation of Xp in the ICM 
is then followed by random inactivation (rXCI) of either the paternal or maternal X chromosome in cells of the 
developing epiblast. In vitro, mouse embryonic stem cells (mESCs) have been extensively used to model rXCI. 
In fact, undifferentiated mESCs carry two active X chromosomes and faithfully mimic the pluripotent environ-
ment of the ICM, whereas their differentiation results in random inactivation of one of the two X chromosomes. 
Mouse ESC-based in vitro studies have led to the discovery of the long non-coding gene Tsix, which is transcribed 
antisense to Xist and represents the major repressor of Xist up-regulation at the onset of XCI15–18. XCI is tightly 
linked to loss of the pluripotent state19,20 and several pluripotency factors including NANOG, SOX2, OCT4, REX1 
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and PRDM14 have been described to function as XCI-inhibitors either by directly inhibiting Xist expression or 
by enhancing Tsix21–24. Activation of XCI is mediated by the X-linked E3 ubiquitin ligase RNF12 involved in 
dose-dependent degradation of REX125,26. Since Rnf12−/− mouse ESCs fail to upregulate Xist upon differentia-
tion, Rnf12 has been suggested to be essential for the initiation of XCI27. In vivo, female embryos that maternally 
inherited an Rnf12 null allele fail to initiate iXCI on the paternal X chromosome and die in utero28, whereas 
RNF12 has been shown to be dispensable for rXCI to occur29. Thus, further research is needed to better under-
stand the observed discrepancies between in vivo and in vitro studies. Interestingly, the study of XCI in female 
pre-implantation embryos from different species suggested that the epigenetic processes that mediate XCI might 
be more heterogeneous than expected. Indeed, iXCI occurs in the extra-embryonic lineages of rat and cow30–32 
whereas in other species such as human, monkey, horse, pig and rabbit, rXCI has been exclusively observed in 
both embryonic and extra-embryonic tissues33,34. Comparative analysis of Xist RNA expression dynamics and 
X-linked gene silencing between rabbit and human pre-implantation embryos confirmed substantial diversity in 
the timing and regulation of XCI initiation among mammals, with cells of the human ICM showing two active 
X chromosomes regardless of Xist RNA coating30. In addition, the overall Xist gene structure appears to be con-
served in all placental mammals32. For instance, comparative analysis of mouse and rat Xist sequence have shown 
that most exons are conserved between the two species, including repeat A, the 5′ element which is required to 
achieve proper gene silencing during XCI35,36. On the other hand, Tsix’s sequence evolved rapidly and differs 
between species37–40. Finally, Tsix antisense transcription through the Xist promoter is absent in human41,42, but 
appears to be conserved in rodents43. Interestingly, differentiation of mouse-rat allodiploid ES cells leads to spe-
cific primary inactivation of the mouse X chromosome44. This mouse allele-biased expression of Xist has been 
proposed to result from the higher expression of Tsix from the rat allele, interfering with expression of Xist in cis44.
Clearly, the development of novel in vitro systems derived from different species is necessary to reach a 
comprehensive understanding of the XCI process. However, although the induced pluripotent stem cell (iPSC) 
technology has allowed the generation of several ES cell-like lines from different species45–47, except for mouse 
iPSCs48, the characterization of the X chromosome status and the generation of in vitro differentiation protocols 
that recapitulate XCI have proven to be challenging49–51. Specific culture conditions that allow studying dosage 
compensation in human ES cells (hESCs) have also been established52,53. These studies provided in vitro systems 
that resemble the pre-XCI state of human pre-implantation embryos, but also showed that hESCs do not undergo 
random XCI upon differentiation. Thus, these observations suggest the presence of an epigenetic memory that 
may affect the faithful recapitulation of XCI as it occurs upon early human development, and highlight the need to 
further optimize cell culture conditions53. In this context, rat ES cells (rESCs)54–62, represent a powerful alternative 
to mESC to study the dynamics of XCI. Although closely related, mouse and rat diverged ~12–24 million years 
ago63, and there are significant differences between the two species. The large-scale structure of the rat genome is 
closer to the human genome than the mouse genome64, and the X chromosome has undergone a higher number 
of rearrangements in the rodent lineages compared to other mammalian orders65,66. Furthermore, compared to 
the mouse, the rat offers several advantages as a model system for modelling human diseases67,68. In functional 
genetic studies, the use of rat as a model system has been limited by the lack of genome engineering tools that 
allow efficient genetic manipulation of rESC. In this context, the development of novel genomic resources that fol-
lowed the sequencing of the rat genome69 and the establishment of the CRISPR/Cas9 technology for genome edit-
ing rapidly enhanced the generation of transgenic rat models70,71 providing the basis to perform genetic studies.
Here, we set out to generate a robust in vitro system that could faithfully mimic the dynamics of XCI in rat. 
By developing a neuronal monolayer differentiation protocol for rESCs adapted from Vaskova and colleagues72, 
we were able to follow several aspects of XCI regulation in rat. Similar to mouse, we were able to observe (I) Xist 
up-regulation at an early stage of rESC differentiation followed by (II) transcriptional inactivation of X-linked 
genes and (III) H3K27me3 accumulation on the inactive X chromosome (Xi). In addition, (IV) overexpression 
experiments in rESCs confirmed that the REX1-RNF12 axis of Xist regulation is most likely conserved between 
rat and mouse. Thus, our data has established the technical basis to study the dynamics of XCI in a different sys-
tem from the mouse and suggests that specific aspects of XCI may be conserved in mouse and rat.
Results
In vitro neuronal differentiation of rESCs. In vitro differentiation of mESCs towards different functional 
cell types including neurons, cardiomyocytes, hepatocytes and pancreatic cells can be efficiently achieved by 
several established protocols73. Usually, differentiation strategies are based on the formation of embryoid bodies 
(EB) followed by growth-factor-mediated induction of early progenitor cells to differentiate into their respective 
lineages. Despite of the growing list of differentiation protocols for mESCs, differentiation of rESCs is extremely 
difficult to achieve in vitro. To date, only two strategies have been described in which rESCs were triggered to 
differentiate into either cardiomyocytes or neuronal precursors and in these differentiation protocols MEK and 
GSK3β inhibitors, that are commonly used for ESC culture, are always present in low concentrations in the dif-
ferentiation media74,75. XCI is closely linked to loss of pluripotency, and the presence of an inactive X chromo-
some provides a powerful readout for cell differentiation. Several rESCs derived from different rat inbred strains 
were differentiated, including three pure Lewis lines (LEW) (A4p20, A9p20, A10p20), and two lines of a mixed 
background of dark agouti (DA) and Sprague-Dawley (SD) (135-7, 141-6). All ESC lines displayed dome shaped 
morphology and expressed the pluripotency factors Rex1, Prdm14, and Esrrb (Fig. 1A,B). We initially set out 
to assess rat XCI after inducing rESCs differentiation according to protocols, which included MEK and GSK3β 
inhibitors. Although female cells appeared to be morphologically differentiated into neuronal precursors, we 
observed enrichment of the H3K27me3 histone modification (hallmark of gene silencing upon XCI) in only 20% 
of the cell population, (Supplementary Fig. 1A). Xist RNA FISH analysis, detecting Xist and Tsix, revealed absence 
of Xist accumulation, and confirmed the presence of small pinpoint transcription signals on both X chromosomes 
in most cells, likely representing Tsix transcription signals, as observed in mouse (Supplementary Fig. 1B). These 
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results indicated our rESCs to be compromised to initiate XCI. We therefore set out to optimize the protocol in 
such a way that differentiation would include proper initiation of XCI. The absence of Xist accumulation and XCI 
might be related to the presence of MEK and GSK3β inhibitors, stabilizing the pluripotent state, and potentially 
resulting in expression of factors that repress Xist20,22–24,57. We therefore adapted the neuronal differentiation pro-
tocol initially described by Peng et al. and Vaskova et al.72,75 as follows: (I) both 2i inhibitors were completely elim-
inated starting from day 1 of neuronal differentiation, (II) the concentration of ROCK (rho-associated protein 
kinase) inhibitor, shown to prevent dissociation-induced apoptosis in cultured human ES cells46,76, was increased, 
(III) cells were seeded on laminin, (IV), a greater number of rESCs was used for differentiation and finally (V) dif-
ferentiation cultures were serum and FGF2 free. Using these modified conditions, we were able to maintain viable 
differentiating male and female rESCs in the absence of 2i inhibitors (Fig. 1A). Importantly, qPCR analysis of both 
pluripotency and differentiation marker expression levels at different time points upon differentiation confirmed 
Figure 1. Neuronal differentiation of rESCs. (a) Schematic representation of our neuronal differentiation 
strategy. Brightfield images of female (A10p20, upper panel) and male (A8p20, lower panel) rESCs at day 0 and 
day 2, 3, 4 and 6 of differentiation are shown. Scale bars represent 80 μm. (b) qPCR analysis of Esrrb, Prdm14, 
Rex1 (pluripotency factors) and Nestin (neuronal differentiation marker) expression levels normalised to Actinb 
in female (A10p20, A4p20) and male (A8p20) differentiating rESCs. Error bars represent standard deviations of 
two technical replicates from one experiment.
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Figure 2. Monoallelic upregulation of Xist RNA upon female rESCs differentiation. (a) Xist and Tsix qPCR 
expression analysis in female (A10p20, A4p20, 135-7, 141-6) and male (A8p20) differentiating rESCs. 
Expression levels of Xist and Tsix at different time points upon neuronal differentiation are shown. In the 
Xist panel error bars represent standard deviation of technical replicates from one experiment. In the Tsix 
panel error bars in A10P20, A4P20 and A8P20 represent standard deviations of technical replicates from 
one experiment and in 135-7 and 141-6 standard deviations of technical replicates from two experiments. 
(b) Representative images of Xist RNA FISH (green) analysis upon differentiation of female (A10p20-upper 
panel) and male (A8p20-lower panel) rESCs. DNA is stained with DAPI (blue). Scale bars represent 10 μm. (c) 
Quantification of relative number of Xist RNA signals (pinpoints or clouds) in A10p20 (left graph) and A4p20 
(right graph) female rESCs at day 0, 2, 3, 4 and 6 upon neuronal differentiation. Xist clouds were never observed 
in male nuclei. More than 100 nuclei were counted for each time point and for each experiment. Error bars 
represent standard deviation of two experimental replicates. Asterisks indicate significant difference between 
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efficient downregulation of the pluripotency factors Esrrb, Prdm14 and Rex1, and parallel up-regulation of the 
neuronal precursor marker Nestin (Fig. 1B).
Female resCs undergo XCI upon in vitro neuronal differentiation. We then addressed the question 
of whether differentiating rESCs without the supplement of 2i inhibitors would facilitate XCI. To this end, four 
independent female rESC lines were differentiated and the Xist RNA expression level was assessed by qPCR 
analysis at different time points upon neuronal differentiation. Importantly, in order to assess the sex-specific 
regulation of Xist RNA, one male rESC line was also included in our analysis. As in mouse, we found that Xist 
upregulation occurs exclusively in female rat cells between day 2 and day 4 of differentiation (Fig. 2A). In contrast, 
Tsix pinpoint signals decrease upon differentiation in all differentiating rESC lines that we tested (Fig. 2A, and 
Supplementary Fig. 2). Next, we addressed the dynamics of Xist expression by performing Xist RNA FISH anal-
ysis at different time points upon neuronal differentiation. In undifferentiated rESCs, Xist RNA pinpoint signals 
were observed within the nuclei of both female and male cells (Fig. 2B). However, since the Xist RNA FISH probe 
can hybridize to both Xist and Tsix RNA, the pinpoint signal might represent Tsix expression instead of Xist. 
Around day 2 of neuronal differentiation, Xist RNA starts to accumulate exclusively on a single X chromosome 
within female nuclei, whereas Xist RNA accumulation was never observed in differentiating male rESCs (Fig. 2B, 
lower panel). Importantly, upon differentiation of A10p20 and A4p20 rESC female lines, more than 60% of the 
nuclei showed an Xist RNA-coated X chromosome at day 6 of differentiation (Fig. 2C). Taken together, these 
observations show that neuronal differentiation of rESCs in absence of 2i inhibitors allows Xist RNA to be upreg-
ulated and spread in cis from a single X chromosome in female cells.
In mouse, the H3K27me3 histone modification associated with gene silencing represents one of the earli-
est histone modifications that accumulates on the Xi during XCI77–79. Therefore, we monitored enrichment of 
H3K27me3 by immunofluorescence analysis upon differentiation of both male and female rESCs. In undifferen-
tiated rESCs, no H3K27me3 domains were observed in neither male nor female cells (Fig. 3A). However, starting 
from day 2 of differentiation and in line with female-specific upregulation of Xist RNA, H3K27me3 started to 
accumulate into specific nuclear domains within female cells. By day 6, more than 60% of the female nuclei 
showed one H3K27me3 domain, thus confirming that XCI is efficiently initiated upon female rESCs differentia-
tion (Fig. 3B). Finally, to precisely assess the dynamics of X-linked gene silencing, we followed the Xist-mediated 
inactivation of the X-linked genes Pgk1 and Rnf12 by two-colour RNA-FISH analysis at different time points 
upon rESCs differentiation. While the single copy of Pgk1 and Rnf12 in male cells remains actively transcribed 
throughout differentiation, the transcriptional inactivation of one copy of both X-linked genes in female cells 
starts around day 2 of differentiation (Fig. 3C and Supplementary Fig. 3). At day 6 of differentiation inactiva-
tion of X-linked genes is reached in up to 70% of the female nuclei (Fig. 3C and Supplementary Fig. 3).
Overexpression of RNF12 leads to Xist activation. The X-linked E3 ubiquitin ligase RNF12 has been 
previously shown to activate Xist transcription at the onset of XCI25,27. Importantly, the pluripotency factor REX1 
has been identified as a key target of RFN12, and dose-dependent degradation of REX1 by RNF12 has been 
proposed to act as a crucial mechanism directing initiation of XCI upon differentiation of female mESCs26. Since 
the RNF12-REX1 axis represents an important pathway for XCI initiation in mouse, we asked whether these 
factors play similar roles in rat XCI. To this end, we transiently overexpressed Rnf12 and Rex1 in rESCs, and 
determined the impact of overexpression on Xist RNA regulation. Based on findings in mouse, we expected 
REX1 overexpression to result in the inhibition of Xist transcription whereas overexpressing RNF12 would lead 
to Xist up-regulation26,27,80. Since the catalytic ring finger domain of RNF12 shows 100% of amino acid sequence 
identity between mouse and rat, and human RNF12 transgenes induce ectopic XCI in mouse ESCs25, we over-
expressed the mouse RNF12 protein (mRNF12) in rESCs. Contrarily, as the zinc finger domain of REX1 is less 
conserved between the two species, overexpression of REX1 was achieved by transfecting rESCs with rat REX1 
cDNA (rREX1). Xist RNA expression levels were determined by qPCR analysis, and the experiment was per-
formed in three independent undifferentiated rESC lines as well as upon neuronal differentiation (Fig. 4A,B). 
Overexpression of mRNF12 consistently resulted in upregulation of Xist RNA in both male and female rESCs 
prior to and during rESCs differentiation, thus indicating RNF12 to act as important trans-acting activator of Xist 
in rat (Fig. 4A,B). Xist RNA FISH analysis performed at day 2 of neuronal differentiation upon mRNF12 overex-
pression further confirmed the impact of RNF12 on XCI initiation (Fig. 4C). However, the impact of rREX1 over-
expression on Xist regulation, prior to and upon differentiation of rESCs, appeared less consistent (Fig. 4A–C). 
Although RNA-FISH and qPCR analysis indicated a decrease in Xist expression when rREX1 is overexpressed 
for one rESC line at day 2 of neuronal differentiation (line 135-7), Xist down-regulation was not significant for 
most comparisons. These results may suggest that Rex1 plays a less prominent role in XCI in rat, but could also be 
explained by our experimental setup, as previously observed in mouse ESCs26, where upregulation of Xist medi-
ated by Rnf12 over-expression was also easier to detect than Rex1 over-expression mediated down-regulation of 
Xist. Although the role of Rex1 in XCI in rat needs further investigation, our findings indicate a role for Rnf12 in 
XCI in rat, providing a powerful new model system to elucidate the complex mechanisms directing initiation of 
XCI.
the two groups (2 pinpoints versus cloud with or without pinpoint) within each differentiation time point. 
P-values are provided: p-valueA10-d0 < 0.0001, p-valueA10-d2 = 0.02, p-valueA10-d3 = 0.03, p-valueA10-d4 = 0.03 and 
p-valueA4-d0 < 0.0001, p-valueA4-d2 = 0.03, p-valueA4-d4 = 0.05, p-valueA4-d6 = 0.03.
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Figure 3. Xist-mediated silencing of X-linked genes. (a) Representative images of H3K27me3 (green) 
immunofluorescence analysis in female (A10p20–upper panel) and male (A8p20-lower panel) rESC at different 
time points upon neuronal differentiation. DNA is stained with DAPI (blue). Scale bars represent 10 μm. (b) 
Quantification of relative number of cells carrying a H3K27me3 domain at day 0, 2, 3, 4 and 6 of neuronal 
differentiation. Data of A10p20 (left graph) and A4p20 (right graph) female rESC lines are shown. H3K27me3 
domains were never noticed in male nuclei. More than 100 nuclei were counted for each time point and in each 
experimental replicate. Error bars represent standard deviations between two experiments. Asterisks indicate 
significant differences between the two groups (absence versus presence of domain) within each differentiation 
time point. The p-values are the given: p-valueA10-d0 < 0.0001, p-valueA10-d2 = 0.003 and p-valueA4-d0 < 0.0001, 
p-valueA4-d2 = 0.03, p-valueA4-d4 = 0.04. (c) Representative images of Xist (green)/Pgk1 (red) two-colour 
RNA-FISH in both female (A10p20-upper panel) and male (A8p20-lower panel) D0 and D6 differentiating 
rat cells are shown. DNA is stained with DAPI (blue). Scale bars represent 10 μm. (d) Xist (green)/Pgk1 (red) 
two-colour RNA-FISH quantitative analysis at different time points during neuronal differentiation of female 
(A10p20-upper panel) and male (A8p20-lower panel) rESCs. The relative number of cells showing either 
biallelic or monoallelic Pgk1 expression is quantified, together with the relative number of cells carrying Xist 
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Discussion
Our knowledge concerning the regulation of XCI in developing rat embryos is limited and relies on conservation 
of the key regulators Xist and Tsix between mouse and rat and a few studies in which, similar to mouse, iXCI has 
been proposed to occur in early rat embryonic development30,37–40. Studying the XCI process in rESCs offers the 
opportunity to explore species-specific epigenetic features and will help to reach a more comprehensive under-
standing of the XCI process in mammals. Although rESCs in vitro differentiation protocols have been previ-
ously established72,74,75, XCI studies were limited, only examining Xist expression and accumulation of chromatin 
modifications. Here, we confirm the accumulation of XCI-related epigenetic features in rESCs during differen-
tiation according to the previously established protocols, and further show that this is accompanied by proper 
down-regulation of pluripotency markers81. We also showed that transcriptional inactivation of X-linked genes 
directly follows Xist RNA accumulation on one of the two X chromosomes. In fact, the exclusive enrichment of 
H3K27me3 loci in female nuclei starts around day 3 of neuronal differentiation, and Xist-mediated silencing of 
Pgk1 and Rnf12 occurs with similar dynamics.
Overexpression of mRNF12 protein in rESCs efficiently recapitulates RNF12 function in mouse as an acti-
vator of Xist expression. RNF12 is highly conserved among mammals82. The observed up-regulation of rat Xist 
upon mRNF12 overexpression is in line with our previous findings that overexpression of human RNF12 leads 
to ectopic Xist expression and XCI in mESCs25, indicating that the role of RNF12 in XCI is highly conserved 
in mammals. In contrast, rREX1 over-expression does not lead to consistent down-regulation of Xist levels as 
was expected based on our mouse studies. This result may indicate the presence of an alternative pathway by 
which RNF12 activates XCI in rat, a theory that is supported by the lower level of conservation in the REX1 
zinc finger domain. On the contrary, REX1 represents the only target of RNF12 in mouse ESCs identified so far. 
In addition, measuring down-regulation of Xist expression in the present setting after transient transfection is 
technically more challenging than detecting up-regulation of Xist, and may require more sensitive approaches to 
experimentally define the exact role of Rex1 in XCI in rat. Additional alternative approaches, such as inducible 
over-expression of Rex1, and ChIP sequencing studies should shed more light on the exact role of Rex1 in XCI 
regulation.
In conclusion, we were able to set up a robust in vitro system to study the regulation of XCI in differentiating 
rESCs and our results suggest that the main steps of XCI in our rat in vitro system are highly similar to those of 
mouse XCI. The generation of hybrid F1 polymorphic rESCs together with the application of the CRISPR/Cas9 
technology for genomic editing to the rat system will increase the use of rat as a model organism in basic epige-
netic and biomedical research.
Methods
Cell culture and DNA transfection. rESCs were derived as previously described56 and subsequently main-
tained in N2B27 medium supplemented with 3 μM CHIR99021 (Stemgent), 1 μM PD0325901 and 1000 U/ml 
mouse LIF on mouse feeders.
For monolayer differentiation culture plates were coated with 100 μg/ml laminin (Sigma-Aldrich) for at 
least 4 hours at 37 °C, followed by three PBS washes. Single rESCs were plated at a density of 105/cm2 for the 
female cell lines and 2 × 104/cm2 for the male cell lines in N2B27 supplemented with 10 μM of ROCK inhibitor 
(Sigma-Aldrich) for the first three days. Thereafter, the ROCK inhibitor was eliminated. Medium was refreshed 
daily.
For overexpression experiments, the mRex1, rRex1 and mRnf12 coding sequences were subcloned into 
pCAG-Flag, a CAG-driven expression vector containing a Flag-tag. RESCs were transfected using lipofectamine 
2000 (Invitrogen) according to the manufacturer’s instructions, followed by 48 hours of puromycin selection 
(1,5 μg/ml). Overexpression in differentiating cells was performed as follows: rESCs were trypsinised and plated 
at a density of 1,3*105/cm2 in gelatinized 6-well plates in 2i media supplemented with 10 μM of ROCK inhibi-
tor (Sigma-Aldrich) without feeders. The next day cells were transfected using lipofectamine 2000 (Invitrogen) 
according to the manufacturer’s instructions. Cells were left to recover in 2i media overnight and then a 48 
hour-puromycin selection (0,25 μg/ml for the A10p20, A4p20 and A8p20 cell lines and 1 μg/ml for the 135-7 cell 
line) was initiated in N2B27 differentiation media.
probe preparation and Fluorescent in Situ Hybridization (FISH). For preparing probes detecting 
Xist, Pgk1 and Rnf12 mRNAs, BACs harboring these genes were labelled as a whole, with digoxigenin and biotin 
(Roche) respectively, by nick translation following the manufacturer’s instructions.
For RNA-FISH at different time points of neuronal differentiation and after overexpression experiments 
during differentiation, cells were grown on glass coverslips and then fixed with 3% PFA for 10 minutes on ice, 
pinpoints or cloud signals. More than 100 nuclei were counted for each time point and in each experiment, 
with exception of A10p20 experimental replicate 2, where at day 2, 50 nuclei were counted. Error bars represent 
standard deviation of two experimental replicates. Asterisks indicate significant differences between groups 
(biallelic expression versus biallelic expression and Xist cloud versus monoallelic expression) within each 
differentiation time point. P-values are provided: p-valueA10-d0bial. VS A10-d0bial.&cloud < 0.0001, p-valueA10-d0bial. VS A10-
d0monal. < 0.0001, p-valueA10-d2bial. VS A10-d2monal. = 0.049, p-valueA10-d6bial. VS A10-d6monal. < 0.0001, p-valueA10-d6bial.&cloud 
VS A10-d6monal. < 0.0001, p-valueA10-d6bial. VS A10-d6bial&cloud. = 0.00076 and p-valueA4-d0bial. VS A4-d0bial.&cloud < 0.0001, 
p-valueA4-d0bial. VS A4-d0monal. < 0.0001, p-valueA4-d6bial. VS A4-d6monal. = 0.0047, p-valueA4-d6bial.& VS A4-d6bial.&cloud = 0.003 
and p-valueA8-d0monal. VS A8-d0monal.&cloud < 0.0001 p-valueA8-d2monal. VS A8-d2monal.&cloud < 0.0001, p-valueA8-d6monal. VS A8-
d6monal.&cloud < 0.0001.
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Figure 4. RNF12 and REX1 overexpression in rESCs and differentiating rESCs. (a) qPCR analysis of Xist, Rex1 
and Rnf12 expression levels after overexpression of rat REX1 and mouse RNF12 proteins in undifferentiated 
rat ESCs. The controls (overexpression of empty vectors) were set to 1 for every gene analysed in each cell line 
used. Error bars represent standard deviation between technical replicates of three experiments. Asterisks and 
hashtags indicate significant differences, with the following p-values: p-value_A10Xist-Control VS Xist-OE_Rnf12 = 0.02, 
p-value_A10Xist-OE_Rex1 VS Xist-OE_Rnf12 = 0.03, p-value_A10Rnf12-Control VS Rnf12-OE_Rnf12 < 0.001, p-value_A10Rnf12-OE_Rex1 
VS Rnf12-OE_Rnf12 < 0.001, p-value_A10Rnf12-OE_Rnf12 VS Rnf12-OE_Rex1 < 0.001, p-value_A10Rex1-Control VS Rex1-OE_Rex1 < 0.001, 
p-value_A10Rex1-OE_Rex1 VS Rex1-OE_Rnf12 < 0.001, (#)p-value_A10Rnf12-Control VS Rnf12-OE_Rex1 = 0.01, p-value_A4Xist-Control 
VS Xist-OE_Rnf12 < 0.001, p-value_A4Xist-OE_Rex1 VS Xist-OE_Rnf12 = 0.001, (#)p-value_A4Xist-Control VS Xist-OE_Rex1 = 0,002, 
p-value_A4Rnf12-Control VS Rnf12-OE_Rnf12 < 0.001, p-value_A4Rnf12-OE_Rex1 VS Rnf12-OE_Rnf12 < 0.001, (#)p-value_A4Rnf12-
Control VS Rnf12-OE_Rex1 = 0.06, p-value_A4Rex1-Control VS Rex1-OE_Rex1 < 0.001, p-value_A4Rex1-OE_Rex1 VS Rex1-OE_Rnf12 < 0.001, 
p-value_A8Xist-Control VS Xist-OE_Rnf12 = 0.02, p-value_A8Xist-OE_Rex1 VS Xist-OE_Rnf12 = 0.03, p-value_A8Rnf12-Control VS 
Rnf12-OE_Rnf12 = 0.02, p-value_A8Rnf12-OE_Rex1 VS Rnf12-OE_Rnf12 = 0.02, p-value_A8Rex1-Control VS Rex1-OE_Rex1 = 0.02, 
p-value_A8Rex1-OE_Rex1 VS Rex1-OE_Rnf12 = 0.02. (b) qPCR analysis of Xist, Rex1 and Rnf12 expression levels after 
overexpression of rat REX1 and mouse RNF12 proteins in day 2 differentiating rat ESCs to neurons. The controls 
(overexpression of empty vectors) were set to 1 for every gene analysed in each cell line used. Error bars represent 
standard deviation between technical replicates from two experiments. Asterisks indicate significant differences 
with the following p-values: p-value_A10Rnf12-Control VS Rnf12-OE_Rnf12 = 0.007, p-value_A10Rnf12-OE_Rex1 VS Rnf12-OE_
Rnf12 = 0.02, p-value_A10Rex1-Control VS Rex1-OE_Rex1 < 0.001, p-value_A10Rex1-OE_Rex1 VS Rex1-OE_Rnf12 < 0.001, p-value_
A4Xist-Control VS Xist-OE_Rnf12 < 0.001, p-value_A4Xist-OE_Rex1 VS Xist-OE_Rnf12 < 0.001, p-value_A4Rnf12-Control VS Rnf12-OE_
Rnf12 = 0.02, p-value_A4Rnf12-OE_Rex1 VS Rnf12-OE_Rnf12 < 0.001, p-value_A4Rex1-Control VS Rex1-OE_Rex1 < 0.001, p-value_
A4Rex1-OE_Rex1 VS Rex1-OE_Rnf12 < 0.001, p-value_135-7Xist-Control VS Xist-OE_Rnf12 < 0.01, p-value_135-7Xist-OE_Rex1 VS 
Xist-OE_Rnf12 < 0.001, (#)p-value_135-7Xist-Control VS Xist-OE_Rex1 = 0.007, p-value_135-7Rnf12-Control VS Rnf12-OE_Rnf12 < 0.001, 
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followed by three washes in PBS. Next, cells were permeabilised with 0.5% Triton and washed again three times 
in PBS. Cytoplasm was removed by treating the cells with 0.025% pepsin in 0.01 N HCL for 3 minutes at 37 °C. 
Subsequently, cells were dehydrated with sequential ethanol washes (70%, 85% and 100% 2 minutes each) and 
air-dried. Finally, probes were applied on the samples overnight at 37 °C in a 50% Formamide/2XSSC humid 
chamber. The next day, slides were washed two times, 5 minutes each, in 50% Formamide/2xSSC pH = 7.4 at 
37 °C, followed by two washes, 5 minutes each in 2xSSC at 37 °C and cells were blocked for 30 minutes at room 
temperature with TSBSA (2 mg/ml bovine serum albumin in 0.1 M Tris and 0.15 M NaCl) in a humid chamber at 
room temperature. Detection was performed by incubation with anti-digoxigenin FITC (Boehringer, 1:250) and 
streptavidin alexa fluor 555 (Thermofisher Scientific, 1:400) in TSBSA for 30 minutes at room temperature. Slides 
were then washed two times, 5 minutes each with TS (0.1 M Tris, 0.15 M NaCl) and mounted with ProLong® Gold 
Antifade Mountant with Dapi (ThermoFisher Scientific). Imaging was performed on a Zeiss LSM700 microscope 
(Carl Zeiss, Jena).
expression analysis. Cells were lysed by direct addition of 500 μl of TRIZOL and total RNA was extracted 
according to the manufacturer’s instructions (Invitrogen). To remove genomic DNA contamination, samples were 
treated 15 minutes at 37 °C with DNaseI (Invitrogen). Next, 1 μg of RNA was reverse transcribed by Superscript 
II reverse transcriptase with random hexamers (Invitrogen). For quantitative PCR (qPCR) gene expression 
levels were quantified using 2x SYBR Green PCR Master Mix (Applied Biosystems) in a CFX384 Real-Time 
machine (Bio-Rad). Expression levels were normalized to Actinb using the Δ-CT method. The primers used 
were as follows: Xist forward TGCCTGGATTTAGAGGAG and reverse CTCCACCTAGGGATCGTCAA, 
Tsix forward CGGACTATCTCCGCTTCTTG and reverse CACCTCTCTGGCTTCTTCCA, Nanog forward 
TAGCCCTGATTCTTCTAGCA and reverse TTTGCTGCAACGGCACATAA, Essrb forward GGCGTTCTTCAA 
GAGAACCA and reverse CCCACTTTGAGGCATTTCAT, Prdm14 forward AGGAACTGCGCTTCGTTCT and 
reverse GGCATCACCAAAAGCTGTCT, Rex1 forward AAATCATGACGAGGCAAGGC and reverse TGAGTT 
CGCTCCAACAGTCT, Nestin forward CTCTGCTGGAGGCTGAGAAC and reverse TGGTATCCCAAGG 
AAATTCG, Actinb forward GCTGGCCTTAGAGACCACAG and reverse AAGCAATTCAGCAACACCAA.
Immunocytochemistry. For immunofluorescence analysis of different time points of neuronal differen-
tiation and of overexpression experiments, cells were grown on glass coverslips and then fixed with 3% PFA 
for 10 minutes at room temperature followed by three washes in PBS (3 × 5′). Thereafter, cells were permeabi-
lised with 0.5% Triton, washed with PBS (3 × 5′) and blocked with 2% BSA, 5% donkey serum in PBS (block-
ing solution) for 30 minutes at room temperature. This was followed by anti-H3K27me3 rabbit (Diagenode, 
1:500) incubation, diluted in blocking solution, at 4 °C overnight in a humid chamber. The next day, slides were 
washed in PBS (3 × 5′) and blocked with donkey anti-rabbit alexa fluor 488 (ThermoFischer Scientific, 1:250) 
secondary antibody, diluted in blocking solution for 1 hour at room temperature in a humid chamber. Slides were 
then washed in PBS (3 × 5′) and mounted with ProLong® Gold Antifade Mountant with Dapi (ThermoFisher 
Scientific). Confocal imaging was performed on a Zeiss LSM700 microscope (Carl Zeiss, Jena).
statistical analysis. Statistical significance between the different groups was assessed by student t-test. 
Statistical significance was set at p < 0.05.
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